FDCP
GILD icon

Foster Dykema Cabot & Partners’s Gilead Sciences GILD Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.43K Hold
39
– – ﹤0.01% 274
2025
Q4 		$4.79K Sell
39
-476
-92% -$57.8K ﹤0.01% 286
2025
Q3 		$57.2K Buy
+515
New +$58.5K ﹤0.01% 199
2024
Q3 		– Sell
-200
Closed -$13.7K – 520
2024
Q2 		$13.7K Buy
+200
New +$13.3K ﹤0.01% 250

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Foster Dykema Cabot & Partners's GILD Position: Q1 2026 in Review

Foster Dykema Cabot & Partners held its Gilead Sciences (GILD) position steady in Q1 2026 at 39 shares worth $5.43K. The position accounts for ﹤0.01% of the portfolio, ranked #274.

Foster Dykema Cabot & Partners first reported a position in GILD in Q2 2024 and has held it in 4 quarters since. The position peaked at $57.2K in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Foster Dykema Cabot & Partners held 39 shares of Gilead Sciences worth $5.43K as of Q1 2026.
  • Foster Dykema Cabot & Partners left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q1 2026, its #274 holding.
  • Foster Dykema Cabot & Partners first reported a position in Gilead Sciences in Q2 2024 and has held it in 4 quarters since.
  • Foster Dykema Cabot & Partners's Gilead Sciences position peaked at $57.2K in Q3 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q1 2026, filed 14 May 2026.